Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Robert A. Burger, MD

Robert A. Burger, MD Physician

Director of Clinical Research and Fellowship Program in Gynecologic Oncology Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Burger is a Penn Medicine employed physician.

About Dr. Robert A. Burger

Recognized by America's Top Doctors, 2014

Recognized by Best Doctors in America - 2013-2013-2014

Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2017

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 1999
  • Obstetrics and Gynecology, 1997

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • Gynecologic Cancer Surgery
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy (Uterus Surgery)
  • Hysteroscopy
  • Laparoscopic Supracervical Hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • Loop Electrosurgical Excision Procedure (LEEP)
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Robotic-Assisted Laparoscopic Hysterectomy (RALH)
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: New York University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: UC at Irvine Medical Center

Memberships

American Association for Cancer Research (AACR), National American College of Obstetricians and Gynecologists , National American College of Surgeons (FACS), fellow, National American Medical Association (AMA), National American Society for Colposcopy and Cervical Pathology (ASCCP), National American Society of Clinical Oncology (ASCO), National Contributor, Written Examination Questions, American Board of Obstetrics & Gynecology, Division of Gynecologic Oncology, National Gynecologic Cancer Foundation Membership Committee (GCF), National Gynecologic Cancer Foundation, Editor-in-Chief, Cancer Information, Women’s Cancer Network (http://www.wcn.org), National Gynecologic Oncology Group , National National Cancer Institute (NCI), Investigator, National National Cancer Institute Gynecologic Cancer Steering Committee, National NRG Oncology, International Ovarian Cancer National Alliance Scientific and Medical Advisory Board, National Peer, National Comprehensive Cancer Network - Clinical Practice Guidelines in Oncology, Ovarian Cancer, National Professional Education Committee, Orange County California Unit, American Cancer Society (ACS), Local Scientific Reviewer, National Comprehensive Cancer Network Scientific Review Committee for Grants for Research on Temsirolimus, National Society of Gynecologic Oncology (SGO), National Southwest Oncology Group (SWOG), National The Smithsonian Associates (national member), National Tina's Wish Foundation, National

Hospital Affiliation

Dr. Burger is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Bais C, Mueller B, Brady MF, Mannel RS, Burger RA, Wei W, Marien KM, Kockx MM, Husain A, Birrer MJ: Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses. J Natl Cancer Inst 109 (11): 2017.

Karam A, Ledermann JA, Kim JW, Sehouli J, Gourley C, Katsumata N, Burger RA, Nam BH, Bacon M, Ng C, Pfisterer J, Bekkers RL, Casado-Herraez A, Redondo A, Fujiwara H, Gleeson N, Rosengarten O, Scambia G, Zhu J, Okamoto A, Stuart G, Ochiai K.: Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions. Ann Oncol 28 (4): 711-7,2017.

Buckingham L, Haggerty AF, Zhang X, Burger RA, Morgan MA, Ko EM, Andy UU, Giuntoli RL.: Sexual function following hysterectomy for endometrial cancer: A five-year follow-up investigation. Poster presentation at the 2017 Annual Meeting on Women's Cancer, National Harbor, MD (Abstract) Abstract : 2017.

Copeland LJ, Brady MF, Burger R, Rodgers D, Huang H, Cella D, Fowler JM, Walker JL, Tewari KS, Bender DP, Morris RT, Lowery WJ, Miller DS, Dewdney SB, Spirtos NM, Lele SB, Guntupalli SR, Ueland, FR, Glaser GE, Mannel RS, DiSaia PJ: A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study. Late breaking abstract oral presentation at 2017 Annual Meeting on Women's Cancers, National Harbor, MD (Abstract) Abstract : 2017.

Buechel MF, Brady MF, Wang Y, Mirniaharikandehei S, Liu H. Zheng B, Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, Moore KN, Bookman MA.: Measurements of sarcopenia as predictive biomarkers for response to anti-angiogenic treatment in epithelial ovarian cancer: An NRG/GOG ancillary data analysis of GOG 218. Poster presentation at 2017 Annual Meeting on Women's Cancers, National Harbor, MD (Abstract) Abstract : 2017.

Slaughter KN, Brady MF, Thai T, Wang Y, Zheng B, Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, Moore KN, Bookman MA.: Measurements of adiposity as predictive biomarkers for response to anti-angiogenic treatment in epithelial ovarian cancer: An NRG/GOG ancillary data analysis of GOG 218. Featured poster presentation at 2017 Annual Meeting on Women's Cancers, National Harbor, MD (Abstract) Abstract : 2017.

Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, Burger R, Kim S, Schmitz K, Ko E.: Incidence of venous thromboembolism by type of gynecologic malignancy and surgical modality in the National Surgical Quality Improvement Program International Journal of Gynecological Cancer 27(3): : 581-587,2017.

Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Christea M, Griggs JJ, Levanback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AA: Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. JAMA Oncology 2 (11): 1427-33,2016.

Dean LT, Zhang X, Latif N, Giuntoli R, Lin L, Haggerty A, Kim S, Shalowitz D, Stashwick C, Simpkins F, Burger R, Morgan M, Ko E, Schmitz KS: Race-Based Disparities in Loss of Functional Independence after Hysterectomy for Uterine Cancer Support Care Cancer 24 (8): 3573-80,2016.

Secord AA; Tritchler D; Liu Y; Starr MD; Brady JC; Lankes HA; Hurwitz H; Mannel RS; Tewari KS; O’Malley DM; Gray HJ; Bakhum-Gamez JN; Fujiwara K; Boente M; Deng W; Burger RA; Birrer MJ; Nixon AB: Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovarian cancer (EOC) treated with carboplatin-paclitaxel (CP) +/- bevacizumab (BEV); Results from GOG-0218. American Society of Clinical Oncology Annual Meeting, Chicago, IL. (Abstract) : 2016.

Academic Contact Info

University of Pennsylvania
3400 Civic Center Blvd.
Smilow CTR 8-104

Philadelphia, PA 19104-5156
Phone: (215) 746-4043
Fax: (215) 573-5129
Patient appointments: 800-789-7366 (PENN)